Strona korzysta z plików cookies w celu realizacji usług i zgodnie z Polityką Plików Cookies.
Możesz określić warunki przechowywania lub dostępu do plików cookies w Twojej przeglądarce.
[ X ]

Signing an investment agreement with COVIDVAX sp. z o.o.

Management Board of INNO-GENE S.A. [Inc] (Issuer) informs that on October 6, 2020 it signed an investment agreement with COVIDVAX sp.z o.o. [Ltd.] (KRS 0000845189), headed by prof. Andrzej Mackiewicz.


The subject of the contract is the optional acquisition of shares created after the share capital increase in exchange for obtaining financing for work on the COVID-19 vaccine. The company CovidVax sp.z o.o. [Ltd.] is a target entity established for commercialization of the vaccine against Covid-19 by the team of prof. Andrzej Mackiewicz, who is the author of the new generation vaccine. The company Covidvax sp.z o.o [Ltd.] will have the IP and all property rights to this vaccine.

back